Mashup Score:72
MDPITreatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era - 6 days
Mashup Score:72
# leusm
Mashup Score:46
sanamloghavimd.substack.comRecognize recurrent genetic alterations in AML based on morphology and/or immunophenotype - 1 day
Mashup Score:46
Board review...
-
This one’s good for those studying for the boards or just wanting to be good hematopathologists 😉 #hemepath #leusm Happy Friday! https://t.co/SH4A8XO3yN - view on twitter
Mashup Score:44
American Society of HematologyKey Points. Treatment intensity was not significantly associated with OS or CIR by multivariate analysis in patients with AML responding to therapyAchievement...
-
ELN risk and MRD status supersede treatment intensity in predicting outcomes in patients with #AML achieving a response Alexandre Bazinet of @MDAndersonNews #Leukemia | @BloodAdvances @ASH_Hematology https://t.co/CYqxzDbqb3 #leusm https://t.co/CYqxzDbqb3 - view on twitter
Mashup Score:43
American Society of HematologyHow I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia - 3 days
Mashup Score:43
Systemic treatment of adult patients with acute lymphoblastic leukemia continues to evolve with the introduction of targeted and T-cell activating therapies,...
-
How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia https://t.co/5QCpMsfQG8 #leusm https://t.co/5QCpMsfQG8 - view on twitter
More coverage:
#leusm
Mashup Score:29
American Society of HematologyUsing 3 illustrative cases, Chaer et al discuss the options for the prevention and therapy of COVID-19 infection in patients with hematologic malignancies and...
-
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies [Aug 18, 2022] @FirasElChaer , Auletta, @ChemalyRoy @BloodJournal https://t.co/JIfU1A6USH #bmtsm #CARTcell #leusm #lymsm #mmsm #mpnsm https://t.co/JIfU1A6USH - view on twitter
Mashup Score:12
NatureIn adults with acute lymphoblastic leukemia (ALL), post-transplant relapse is a major risk factor for mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Our...
-
Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemia https://t.co/stmQTrKA8L #ALL #leusm https://t.co/stmQTrKA8L - view on twitter
Mashup Score:9
NatureBlood Cancer Journal – CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical...
-
CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study https://t.co/jCCH7OfjhM #ALL #leusm https://t.co/jCCH7OfjhM - view on twitter
Mashup Score:7
American Association for Cancer ResearchPatients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19 - 6 days
Mashup Score:7
Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients...
-
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZafi #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/IMEbvgZafi - view on twitter
Mashup Score:7
VJHemOncThe promise of CD123-directed immunotherapy in AML and agents of interest - 2 days
Mashup Score:7
Farhad Ravandi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the promise of CD123-directed immunotherapy...
-
There have been some exciting developments in AML with CD123-directed immunotherapy! Watch our interview with @fravandi1 of @MDAndersonNews to learn about promising agents currently under investigation: 🎥 https://t.co/urfUFic27e #AMLsm #LeuSM #ImmunoOnc #ISAL2023 - view on twitter
Mashup Score:6
American Association for Cancer ResearchPatients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19 - 5 days
Mashup Score:6
Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients...
-
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZafi #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/IMEbvgZafi - view on twitter
Richter Transformation (RT) refers to the development of an aggressive lymphoma in the setting of chronic lymphocytic leukemia (CLL). While many variants of RT...
Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era https://t.co/AeX7DVYdjd #mdpicancers via @Cancers_MDPI #leusm https://t.co/AeX7DVYdjd - view on twitter